Smart radiation therapy to protect memory for multiple brain tumors
Part of Brain & nervous system, Cancer clinical trials.
This study tests a targeted way of giving radiation to multiple brain tumors while trying to protect memory areas. It may be an option if you have 6 or more brain metastases that haven't been treated with radiation before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cancer that started elsewhere and has spread to your brain as 6 or more tumors.
- The tumors are not too close to certain memory areas (hippocampus) in your brain.
- You have not had full-brain radiation or radiosurgery for more than 5 brain tumors before.
- You can care for yourself most of the day (Karnofsky score of 60% or higher).
- You are 18 years or older and are willing to use birth control if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways of giving radiation to the brain for people with 5 or more brain metastases: focused stereotactic radiosurgery, or a whole-brain approach that tries to spare the memory area (with memantine). It aims to see which method better protects thinking and memory while still treating the tumors.
This Phase 2 trial tests a brain radiation technique that aims to treat up to a few brain metastases while sparing areas important for thinking and memory. It may help people keep cognitive abilities better than with more brain-wide radiation approaches.
This trial compares two stereotactic radiation strategies for patients who have intact (not previously radiated) brain metastases that are limited in size. It aims to see which approach works best in controlling the cancer while reducing side effects.
This trial tests a local treatment approach (focused radiation) for people with multiple brain metastases. It may help by targeting several spots in the brain while keeping treatment within certain size and safety limits.
This trial is for people with cancer that has spread to the brain (brain metastases). It tests a new approach where you start a systemic therapy (drugs that travel through your body) and later add focused radiation to the brain tumors, instead of treating them right away. The goal is to see if this sequence works well and avoids unnecessary side effects.
This Phase 2 study tests a treatment plan that combines whole-brain radiation therapy with an additional approach to help people with brain metastases. It aims to improve outcomes while also tracking brain function and memory over time.
Hear when a new Brain Metastases From Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.